{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 407389823
| IUPAC_name = 1-(2-Diethylaminoethylamino)-4-(hydroxymethyl)-9-thioxanthenone
| image = Hycanthone.png

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 3105-97-3
| ATC_prefix = none
| ATC_suffix =  
| PubChem = 3634
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = 2BXX5EVN2A
| ChEBI_Ref = {{ebicite|changed|EBI}}
| ChEBI = 52768
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00541
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 22077
|  ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 3508
|  StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C20H24N2O2S/c1-3-22(4-2)12-11-21-16-10-9-14(13-23)20-18(16)19(24)15-7-5-6-8-17(15)25-20/h5-10,21,23H,3-4,11-13H2,1-2H3
|  StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = MFZWMTSUNYWVBU-UHFFFAOYSA-N

<!--Chemical data-->
| chemical_formula =  
| C=20 | H=24 | N=2 | O=2 | S=1 
| molecular_weight = 356.48 g/mol
| smiles = CCN(CC)CCNC1=C2C(=C(C=C1)CO)SC3=CC=CC=C3C2=O
}}

'''Hycanthone''' is the [[schistosomicide]] approved by the FDA in 1975.  It is a metabolite of [[lucanthone]]. Hycanthone interferes with [[parasite]] nerve function, resulting in [[paralysis]] and death. This agent also intercalates into DNA and inhibits RNA synthesis ''[[in vitro]]'' and shows potential [[antineoplastic]] activity.<ref>[http://www.cancer.gov/drugdictionary?cdrid=39477 NCI Cancer Dictionary]</ref>

==Anti-schistosomal activity==
Hycanthone is shown to be an effective inhibitor of [[acetylcholinesterase]] (AChE) from ''[[Schistosoma mansoni]]'', but is less potential against AChE from mammalian origin. This might come from differences in the configuration of active center between schistosome and mammalian AChE enzymes..<ref>{{cite journal  | title = Anticholinergic properties of the antischistosomal drug hycanthone |  volume = 24 | issue = 5 | pages = 827–834 | year = 1975 | pmid =1190369  | last1 = Hillman  | first1 = GR  | last2 = Senft  | first2 = AW  | journal = The American journal of tropical medicine and hygiene }}</ref>

Hycanthone is shown to [[Intercalation (biochemistry)|intercalates]] into DNA and inhibit RNA synthesis ''[[in vitro]]''. A growing body of evidence has shown that hycathone has an [[antineoplastic]] activity.

==Clinical trials==
* Phase II Study of Chemotherapy with Hycanthone for Advanced Colorectal Carcinoma (Completed)
* Phase II Chemotherapy with Hycanthone Mesylate and Flagyl for Advanced Malignant Lymphomas (Completed)<ref>http://www.cancer.gov/clinicaltrials/search/results?protocolsearchid=10235377</ref>

==Physical properties==
{| class="wikitable"
|-
| '''[[State of matter|Physical state]]''' || Solid
|-
| '''[[Solubility]]''' || Soluble in ethanol, methanol, DMSO, and water
|-
| '''[[Absorption maximum]]''' || 233, 258, 329, 438 nm 
|-
| '''[[Melting point]]''' || 173-176 °C
|-
| '''[[Partition coefficient|logP]]''' || 3.74
|}
==References==
{{reflist}}

[[Category:Antiparasitic agents]]
[[Category:Thioxanthones]]